Andreas Oliver Frank
Research Subjects
Andreas Oliver Frank has a total of 244 co-authors. Here are the top co-authors by number of shared publications:
- Horst Kessler
Department of Chemistry, School of Natural Sciences and Bavarian NMR Center (BNMRZ), Institute for Advanced Study, Technical University Munich, Lichtenbergstrasse 2a, Garching 85748, Germany
9 shared publications - Andreas Lingel
Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland
8 shared publications - Burkhard Luy
Karlsruhe Institute of Technology (Karlsruhe, Germany)
8 shared publications Andrew Proudfoot
Global Discovery Chemistry Novartis Institutes for BioMedical Research 5300 Chiron Way Emeryville CA 94608 USA
7 shared publicationsMichael D. Feldkamp
Department of Biochemistry Vanderbilt University Nashville TN 37232 USA
7 shared publications- Stephen W. Fesik
Department of Biochemistry, Vanderbilt University School of Medicine, 2215 Garland Avenue, 607 Light Hall, Nashville, Tennessee 37232-0146, United States
7 shared publications
Latest Publications
- 17 August 2026
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (9) , 2006-2016
Covalent Stabilizers of the Interaction Between 14-3-3σ and Estrogen Receptor-α
Selective stabilization of complexes formed by the hub protein 14-3-3 represents an emerging mechanism for the modulation of therapeutically relevant targets. In this letter, we describe a hit-finding campaign designed to identify small molecule stabilizers of the interaction between 14-3-3σ and the estrogen receptor alpha (ERα). Four structurally distinct hits were identified and validated using a combination of biochemical assays and biophysical techniques. Ternary complex crystal structures revealed that all four hit compounds form a covalent bond with Cys38 of 14-3-3σ via four different electrophilic warheads. Structure-based optimization of the most promising hit compound 9 led to dramatic improvements in stabilization activity and selectivity that exceeded the complex natural product fusicoccin A.
- 17 August 2026
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 17 (9) , 2006-2016
Covalent Stabilizers of the Interaction Between 14-3-3σ and Estrogen Receptor-α
Selective stabilization of complexes formed by the hub protein 14-3-3 represents an emerging mechanism for the modulation of therapeutically relevant targets. In this letter, we describe a hit-finding campaign designed to identify small molecule stabilizers of the interaction between 14-3-3σ and the estrogen receptor alpha (ERα). Four structurally distinct hits were identified and validated using a combination of biochemical assays and biophysical techniques. Ternary complex crystal structures revealed that all four hit compounds form a covalent bond with Cys38 of 14-3-3σ via four different electrophilic warheads. Structure-based optimization of the most promising hit compound 9 led to dramatic improvements in stabilization activity and selectivity that exceeded the complex natural product fusicoccin A.
- Open Access
- 11 June 2026
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 12 (7) , 1008-1020
Targeted Transcriptional Repression by Induced Proximity
- 11 June 2026
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 12 (7) , 1008-1020
Open AccessTargeted Transcriptional Repression by Induced Proximity
- Open Access
- 27 September 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (19) , 17454-17471
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic Preparedness
The COVID-19 pandemic highlights the ongoing risk of zoonotic transmission of coronaviruses to global health. To prepare for future pandemics, it is essential to develop effective antivirals targeting a broad range of coronaviruses. Targeting the essential and clinically validated coronavirus main protease (Mpro), we constructed a structurally diverse Mpro panel by clustering all known coronavirus sequences by Mpro active site sequence similarity. Through screening, we identified a potent covalent inhibitor that engaged the catalytic cysteine of SARS-CoV-2 Mpro and used structure-based medicinal chemistry to develop compounds in the pyrazolopyrimidine sulfone series that exhibit submicromolar activity against multiple Mpro homologues. Additionally, we solved the first X-ray cocrystal structure of Mpro from the human-infecting OC43 coronavirus, providing insights into potency differences among compound-target pairs. Overall, the chemical compounds described in this study serve as starting points for the development of antivirals with broad-spectrum activity, enhancing our preparedness for emerging human-infecting coronaviruses.
- 27 September 2024
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (19) , 17454-17471
Open AccessIdentification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic Preparedness
The COVID-19 pandemic highlights the ongoing risk of zoonotic transmission of coronaviruses to global health. To prepare for future pandemics, it is essential to develop effective antivirals targeting a broad range of coronaviruses. Targeting the essential and clinically validated coronavirus main protease (Mpro), we constructed a structurally diverse Mpro panel by clustering all known coronavirus sequences by Mpro active site sequence similarity. Through screening, we identified a potent covalent inhibitor that engaged the catalytic cysteine of SARS-CoV-2 Mpro and used structure-based medicinal chemistry to develop compounds in the pyrazolopyrimidine sulfone series that exhibit submicromolar activity against multiple Mpro homologues. Additionally, we solved the first X-ray cocrystal structure of Mpro from the human-infecting OC43 coronavirus, providing insights into potency differences among compound-target pairs. Overall, the chemical compounds described in this study serve as starting points for the development of antivirals with broad-spectrum activity, enhancing our preparedness for emerging human-infecting coronaviruses.
- Top Cited PapersOpen Access
- 11 April 2023
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 9 (5) , 915-926
Rational Chemical Design of Molecular Glue Degraders
- 11 April 2023
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 9 (5) , 915-926
Top Cited PapersOpen AccessRational Chemical Design of Molecular Glue Degraders
- Top Cited Papers
- 24 February 2022
- Published by Springer Nature in Nature Chemical Biology
- Vol. 18 (4) , 412-421
Deubiquitinase-targeting chimeras for targeted protein stabilization
Many diseases are driven by proteins that are aberrantly ubiquitinated and degraded. These diseases would be therapeutically benefited by targeted protein stabilization (TPS). Here we present deubiquitinase-targeting chimeras (DUBTACs), heterobifunctional small molecules consisting of a deubiquitinase recruiter linked to a protein-targeting ligand, to stabilize the levels of specific proteins degraded in a ubiquitin-dependent manner. Using chemoproteomic approaches, we discovered the covalent ligand EN523 that targets a non-catalytic allosteric cysteine C23 in the K48-ubiquitin-specific deubiquitinase OTUB1. We showed that a DUBTAC consisting of our EN523 OTUB1 recruiter linked to lumacaftor, a drug used to treat cystic fibrosis that binds ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR), robustly stabilized ΔF508-CFTR protein levels, leading to improved chloride channel conductance in human cystic fibrosis bronchial epithelial cells. We also demonstrated stabilization of the tumor suppressor kinase WEE1 in hepatoma cells. Our study showcases covalent chemoproteomic approaches to develop new induced proximity-based therapeutic modalities and introduces the DUBTAC platform for TPS.
- 24 February 2022
- Published by Springer Nature in Nature Chemical Biology
- Vol. 18 (4) , 412-421
Top Cited PapersDeubiquitinase-targeting chimeras for targeted protein stabilization
Many diseases are driven by proteins that are aberrantly ubiquitinated and degraded. These diseases would be therapeutically benefited by targeted protein stabilization (TPS). Here we present deubiquitinase-targeting chimeras (DUBTACs), heterobifunctional small molecules consisting of a deubiquitinase recruiter linked to a protein-targeting ligand, to stabilize the levels of specific proteins degraded in a ubiquitin-dependent manner. Using chemoproteomic approaches, we discovered the covalent ligand EN523 that targets a non-catalytic allosteric cysteine C23 in the K48-ubiquitin-specific deubiquitinase OTUB1. We showed that a DUBTAC consisting of our EN523 OTUB1 recruiter linked to lumacaftor, a drug used to treat cystic fibrosis that binds ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR), robustly stabilized ΔF508-CFTR protein levels, leading to improved chloride channel conductance in human cystic fibrosis bronchial epithelial cells. We also demonstrated stabilization of the tumor suppressor kinase WEE1 in hepatoma cells. Our study showcases covalent chemoproteomic approaches to develop new induced proximity-based therapeutic modalities and introduces the DUBTAC platform for TPS.
- Open Access
- 13 November 2020
- Published by American Chemical Society (ACS)
Comprehensive and high-throughput exploration of chemical space using broadband 19F NMR-based screening
- 13 November 2020
- Published by American Chemical Society (ACS)
Open AccessComprehensive and high-throughput exploration of chemical space using broadband 19F NMR-based screening
- Open Access
- 4 August 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (35) , 14698
Inside Cover: Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening (Angew. Chem. Int. Ed. 35/2020)
- 4 August 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (35) , 14698
Open AccessInside Cover: Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening (Angew. Chem. Int. Ed. 35/2020)
- Open Access
- 4 August 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (35) , 14806
Innentitelbild: Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening (Angew. Chem. 35/2020)
- 4 August 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (35) , 14806
Open AccessInnentitelbild: Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening (Angew. Chem. 35/2020)
- 3 May 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (35) , 14919-14927
Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening
Fragment‐based lead discovery has become a fundamental approach to identify ligands that efficiently interact with disease‐relevant targets. Among the numerous screening techniques, fluorine‐detected NMR has gained popularity owing to its high sensitivity, robustness, and ease of use. To effectively explore chemical space, a universal NMR experiment, a rationally designed fragment library, and a sample composition optimized for a maximal number of compounds and minimal measurement time are required. Here, we introduce a comprehensive method that enabled the efficient assembly of a high‐quality and diverse library containing nearly 4000 fragments and screening for target‐specific binders within days. At the core of the approach is a novel broadband relaxation‐edited NMR experiment that covers the entire chemical shift range of drug‐like 19F motifs in a single measurement. Our approach facilitates the identification of diverse binders and the fast ligandability assessment of new targets.
- 3 May 2020
- Published by Wiley in Angewandte Chemie
- Vol. 132 (35) , 14919-14927
Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening
Fragment‐based lead discovery has become a fundamental approach to identify ligands that efficiently interact with disease‐relevant targets. Among the numerous screening techniques, fluorine‐detected NMR has gained popularity owing to its high sensitivity, robustness, and ease of use. To effectively explore chemical space, a universal NMR experiment, a rationally designed fragment library, and a sample composition optimized for a maximal number of compounds and minimal measurement time are required. Here, we introduce a comprehensive method that enabled the efficient assembly of a high‐quality and diverse library containing nearly 4000 fragments and screening for target‐specific binders within days. At the core of the approach is a novel broadband relaxation‐edited NMR experiment that covers the entire chemical shift range of drug‐like 19F motifs in a single measurement. Our approach facilitates the identification of diverse binders and the fast ligandability assessment of new targets.
- 3 May 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (35) , 14809-14817
Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening
Fragment‐based lead discovery has become a fundamental approach to identify ligands that efficiently interact with disease‐relevant targets. Among the numerous screening techniques, fluorine‐detected NMR has gained popularity owing to its high sensitivity, robustness, and ease of use. To effectively explore chemical space, a universal NMR experiment, a rationally designed fragment library, and a sample composition optimized for a maximal number of compounds and minimal measurement time are required. Here, we introduce a comprehensive method that enabled the efficient assembly of a high‐quality and diverse library containing nearly 4000 fragments and screening for target‐specific binders within days. At the core of the approach is a novel broadband relaxation‐edited NMR experiment that covers the entire chemical shift range of drug‐like 19F motifs in a single measurement. Our approach facilitates the identification of diverse binders and the fast ligandability assessment of new targets.
- 3 May 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 59 (35) , 14809-14817
Comprehensive and High‐Throughput Exploration of Chemical Space Using Broadband 19F NMR‐Based Screening
Fragment‐based lead discovery has become a fundamental approach to identify ligands that efficiently interact with disease‐relevant targets. Among the numerous screening techniques, fluorine‐detected NMR has gained popularity owing to its high sensitivity, robustness, and ease of use. To effectively explore chemical space, a universal NMR experiment, a rationally designed fragment library, and a sample composition optimized for a maximal number of compounds and minimal measurement time are required. Here, we introduce a comprehensive method that enabled the efficient assembly of a high‐quality and diverse library containing nearly 4000 fragments and screening for target‐specific binders within days. At the core of the approach is a novel broadband relaxation‐edited NMR experiment that covers the entire chemical shift range of drug‐like 19F motifs in a single measurement. Our approach facilitates the identification of diverse binders and the fast ligandability assessment of new targets.